drugset / Trial / NCT02793557

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

NCT02793557 ↗

Phase 1/2 Completed 44 enrolled Follicum AB
RandomizedParallel-groupTriple-blindTreatment

Summary

A study to investigate clinical safety and effect on hair growth of FOL-005 in healthy volunteers. The study is divided in two parts, a single ascending dose (SAD) part and a multiple dose (MD) part.

Timeline

Start
2016-01
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject FOL-005 Unknown 0.05 ml Other

Indications